Poland

Poland

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.32 (0.23 - 0.42) 2015 Modelled WHO
0.9 (0.70 - 1.10) 2016 Modelled Razavi-Shearer et al, 2018
0.42 (0.42 - 0.43) 2013 Modelled Schweitzer et al, 2015
0.44 (0.39 - 0.49) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.48 (0.43 - 0.54) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.43 - 0.54) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.44 - 0.56) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.46 - 0.57) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.53 (0.47 - 0.59) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.55 (0.49 - 0.61) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.51 - 0.64) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.53 - 0.67) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.55 - 0.69) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.56 - 0.71) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.59 - 0.73) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.61 - 0.76) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.63 - 0.79) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.65 - 0.81) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.67 - 0.83) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.70 - 0.86) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.73 - 0.89) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.76 - 0.92) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.78 - 0.95) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.80 - 0.97) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.82 - 0.99) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.84 - 1.01) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.86 - 1.04) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.87 - 1.05) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.89 - 1.07) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.90 - 1.09) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.91 - 1.10) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.92 - 1.12) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.92 - 1.13) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.48 (0.43 - 0.53) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.04 (0.02 - 0.06) 2015 Modelled WHO
0.02 (0.02 - 0.03) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.03 (0.02 - 0.04) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.03 - 0.04) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.03 - 0.04) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.17) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.17 - 0.28) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.24 - 0.39) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.37 (0.29 - 0.47) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.32 - 0.52) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.34 - 0.56) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.48 (0.36 - 0.60) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.38 - 0.62) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.51 (0.39 - 0.64) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.01 (0.01 - 0.02) 2020 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
2.9 2017 Survey/reported ECDC
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
2.9 2017 Survey/reported EMCDDA
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
359,000 (269,000 - 438,000) 2016 Modelled Razavi-Shearer et al, 2018
170,081 (150,631 - 189,962) 2019 Modelled IHME, GBD 2019 (accessed 2020)
175,512 (155,792 - 195,093) 2019 Modelled IHME, GBD 2019 (accessed 2022)
177,041 (157,005 - 197,038) 2018 Modelled IHME, GBD 2019 (accessed 2022)
178,641 (157,946 - 198,879) 2017 Modelled IHME, GBD 2019 (accessed 2022)
183,507 (162,345 - 203,811) 2016 Modelled IHME, GBD 2019 (accessed 2022)
189,441 (168,520 - 209,849) 2015 Modelled IHME, GBD 2019 (accessed 2022)
194,599 (172,873 - 215,702) 2014 Modelled IHME, GBD 2019 (accessed 2022)
202,479 (179,755 - 225,079) 2013 Modelled IHME, GBD 2019 (accessed 2022)
211,492 (186,863 - 235,696) 2012 Modelled IHME, GBD 2019 (accessed 2022)
219,910 (194,126 - 244,933) 2011 Modelled IHME, GBD 2019 (accessed 2022)
225,952 (199,225 - 251,875) 2010 Modelled IHME, GBD 2019 (accessed 2022)
231,880 (206,047 - 257,835) 2009 Modelled IHME, GBD 2019 (accessed 2022)
240,271 (213,852 - 266,199) 2008 Modelled IHME, GBD 2019 (accessed 2022)
249,762 (221,871 - 277,534) 2007 Modelled IHME, GBD 2019 (accessed 2022)
258,920 (230,075 - 287,324) 2006 Modelled IHME, GBD 2019 (accessed 2022)
266,191 (237,576 - 294,434) 2005 Modelled IHME, GBD 2019 (accessed 2022)
273,693 (244,859 - 302,673) 2004 Modelled IHME, GBD 2019 (accessed 2022)
283,620 (254,754 - 313,546) 2003 Modelled IHME, GBD 2019 (accessed 2022)
294,462 (265,423 - 324,980) 2002 Modelled IHME, GBD 2019 (accessed 2022)
304,704 (275,268 - 336,117) 2001 Modelled IHME, GBD 2019 (accessed 2022)
312,712 (282,366 - 344,365) 2000 Modelled IHME, GBD 2019 (accessed 2022)
319,801 (288,727 - 351,667) 1999 Modelled IHME, GBD 2019 (accessed 2022)
327,829 (296,757 - 360,087) 1998 Modelled IHME, GBD 2019 (accessed 2022)
335,998 (304,922 - 368,513) 1997 Modelled IHME, GBD 2019 (accessed 2022)
343,584 (312,229 - 376,577) 1996 Modelled IHME, GBD 2019 (accessed 2022)
349,785 (317,940 - 383,612) 1995 Modelled IHME, GBD 2019 (accessed 2022)
354,877 (322,193 - 389,564) 1994 Modelled IHME, GBD 2019 (accessed 2022)
359,530 (325,720 - 395,148) 1993 Modelled IHME, GBD 2019 (accessed 2022)
363,616 (329,448 - 400,170) 1992 Modelled IHME, GBD 2019 (accessed 2022)
367,003 (332,234 - 405,124) 1991 Modelled IHME, GBD 2019 (accessed 2022)
369,340 (334,000 - 408,672) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.57 (3.59 - 5.73) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.66 (6.05 - 7.32) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7 (6.36 - 7.68) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6.88 (6.27 - 7.55) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6.66 (6.07 - 7.32) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.69 (6.12 - 7.34) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.86 (6.24 - 7.55) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.72 (6.11 - 7.42) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6.68 (6.05 - 7.38) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.69 (6.09 - 7.35) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6.84 (6.17 - 7.53) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.57 (5.94 - 7.28) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.51 (5.88 - 7.20) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.43 (5.77 - 7.12) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.39 (5.74 - 7.10) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.62 (5.92 - 7.39) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.56 (5.89 - 7.32) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.54 (5.81 - 7.34) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.21 (5.48 - 7.04) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.64 (4.93 - 6.45) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4.73 (4.07 - 5.46) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.07 (4.40 - 5.83) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4.69 (4.02 - 5.40) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4.71 (4.04 - 5.41) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.61 (3.97 - 5.30) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.46 (3.84 - 5.16) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4.57 (3.94 - 5.26) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4.56 (3.80 - 5.38) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4.57 (3.94 - 5.24) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4.57 (3.67 - 5.62) 2018 Modelled IHME, GBD 2019 (accessed 2022)
4.57 (3.59 - 5.73) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
2,081 2016 Modelled WHO
2,540 (2,309 - 2,792) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2,676 (2,434 - 2,938) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,635 (2,402 - 2,892) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,555 (2,328 - 2,808) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,571 (2,350 - 2,817) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,633 (2,398 - 2,898) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,567 (2,339 - 2,821) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,620 (2,363 - 2,887) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,579 (2,347 - 2,847) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,564 (2,321 - 2,831) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,517 (2,275 - 2,788) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,492 (2,251 - 2,756) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,457 (2,207 - 2,721) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,442 (2,194 - 2,711) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2,503 (2,248 - 2,795) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,527 (2,262 - 2,822) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,496 (2,221 - 2,805) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,372 (2,094 - 2,689) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,159 (1,888 - 2,467) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,944 (1,686 - 2,234) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,800 (1,543 - 2,073) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,814 (1,561 - 2,094) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,812 (1,555 - 2,082) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,775 (1,526 - 2,040) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,715 (1,477 - 1,985) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,757 (1,514 - 2,016) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,755 (1,464 - 2,069) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,757 (1,516 - 2,025) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,756 (1,412 - 2,160) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,755 (1,380 - 2,203) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,755 (1,380 - 2,203) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
19 (16 - 22) 1990 Modelled IHME, GBD 2019 (accessed 2022)
18 (15 - 21) 1991 Modelled IHME, GBD 2019 (accessed 2022)
17 (15 - 20) 1992 Modelled IHME, GBD 2019 (accessed 2022)
16 (14 - 19) 1993 Modelled IHME, GBD 2019 (accessed 2022)
15 (13 - 18) 1994 Modelled IHME, GBD 2019 (accessed 2022)
14 (12 - 16) 1995 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 14) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 10) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 6) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 8) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2019 Modelled IHME, GBD 2019 (accessed 2022)
18 (15 - 21) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
93 2019 Survey/reported WHO/UNICEF
93 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
93 2016 Survey/reported WHO/UNICEF
93 2015 Survey/reported WHO/UNICEF
93 2014 Survey/reported WHO/UNICEF
93 2013 Survey/reported WHO/UNICEF
93 2012 Survey/reported WHO/UNICEF
93 2011 Survey/reported WHO/UNICEF
93 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
93 2008 Survey/reported WHO/UNICEF
93 2007 Survey/reported WHO/UNICEF
93 2006 Survey/reported WHO/UNICEF
93 2005 Survey/reported WHO/UNICEF
93 2004 Survey/reported WHO/UNICEF
92 2003 Survey/reported WHO/UNICEF
94 2002 Survey/reported WHO/UNICEF
94 2001 Survey/reported WHO/UNICEF
95 2000 Survey/reported WHO/UNICEF
79 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2019 Survey/reported WHO/UNICEF
90 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
18 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2001
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.5 (0.40 - 0.60) 2015 Modelled Blach et al, 2017
1.19 (0.96 - 1.47) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (0.95 - 1.46) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (0.95 - 1.45) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.19 (0.96 - 1.46) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.97 - 1.48) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.97 - 1.49) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.97 - 1.49) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.97 - 1.50) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.97 - 1.50) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.97 - 1.50) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.2 (0.96 - 1.49) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.2 (0.96 - 1.49) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.19 (0.95 - 1.47) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (0.94 - 1.46) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.17 (0.94 - 1.45) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.93 - 1.43) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.15 (0.91 - 1.41) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.13 (0.90 - 1.39) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.89 - 1.37) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.1 (0.88 - 1.36) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.09 (0.87 - 1.35) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.86 - 1.33) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.86 - 1.33) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.86 - 1.32) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.86 - 1.32) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.86 - 1.33) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.09 (0.88 - 1.35) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.89 - 1.38) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.13 (0.90 - 1.41) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.93 - 1.45) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.13 (0.91 - 1.40) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.33 (0.25 - 0.41) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.1 (1 - 1.20) 2016 Survey/reported Parda N, 2016
1.5 (1.30 - 1.70) 2014 Survey/reported Walewska-Zielecka, 2016
0.8 (0.30 - 1.60) 2006 Survey/reported Clifford, 2017
0.9 (0.60 - 1.10) 2014 Survey/reported Gower et al, 2014
1.94 (1.75 - 2.15) 2010 Survey/reported ECDC
1.1 (1 - 1.20) 2016 Survey/reported ECDC
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
58.7 (55.10 - 62.20) 2005 Survey/reported Rosinska M et al, 2015
57.9 2017 Survey/reported ECDC
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
57.9 2017 Survey/reported EMCDDA
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
184,000 (136,000 - 224,000) 2015 Modelled Blach et al, 2017
419,224 (334,312 - 522,970) 1990 Modelled IHME, GBD 2019 (accessed 2022)
410,628 (328,384 - 511,538) 1991 Modelled IHME, GBD 2019 (accessed 2022)
402,761 (322,303 - 500,707) 1992 Modelled IHME, GBD 2019 (accessed 2022)
396,399 (317,365 - 490,717) 1993 Modelled IHME, GBD 2019 (accessed 2022)
392,147 (314,081 - 483,558) 1994 Modelled IHME, GBD 2019 (accessed 2022)
390,479 (312,780 - 480,861) 1995 Modelled IHME, GBD 2019 (accessed 2022)
390,827 (312,657 - 481,477) 1996 Modelled IHME, GBD 2019 (accessed 2022)
392,148 (313,531 - 483,460) 1997 Modelled IHME, GBD 2019 (accessed 2022)
394,192 (314,659 - 486,711) 1998 Modelled IHME, GBD 2019 (accessed 2022)
396,707 (316,505 - 490,466) 1999 Modelled IHME, GBD 2019 (accessed 2022)
399,475 (318,928 - 494,379) 2000 Modelled IHME, GBD 2019 (accessed 2022)
403,711 (322,282 - 498,756) 2001 Modelled IHME, GBD 2019 (accessed 2022)
409,851 (326,986 - 507,086) 2002 Modelled IHME, GBD 2019 (accessed 2022)
416,598 (333,227 - 515,201) 2003 Modelled IHME, GBD 2019 (accessed 2022)
422,759 (338,224 - 522,645) 2004 Modelled IHME, GBD 2019 (accessed 2022)
427,231 (341,758 - 528,373) 2005 Modelled IHME, GBD 2019 (accessed 2022)
430,566 (344,932 - 533,869) 2006 Modelled IHME, GBD 2019 (accessed 2022)
433,862 (347,632 - 538,767) 2007 Modelled IHME, GBD 2019 (accessed 2022)
436,931 (350,160 - 542,588) 2008 Modelled IHME, GBD 2019 (accessed 2022)
439,591 (351,566 - 545,830) 2009 Modelled IHME, GBD 2019 (accessed 2022)
441,680 (354,033 - 548,271) 2010 Modelled IHME, GBD 2019 (accessed 2022)
443,004 (354,300 - 550,476) 2011 Modelled IHME, GBD 2019 (accessed 2022)
443,504 (355,173 - 548,495) 2012 Modelled IHME, GBD 2019 (accessed 2022)
443,349 (356,089 - 545,697) 2013 Modelled IHME, GBD 2019 (accessed 2022)
442,832 (356,572 - 542,534) 2014 Modelled IHME, GBD 2019 (accessed 2022)
442,067 (355,543 - 540,940) 2015 Modelled IHME, GBD 2019 (accessed 2022)
435,797 (350,604 - 536,777) 2016 Modelled IHME, GBD 2019 (accessed 2022)
430,631 (347,347 - 530,310) 2017 Modelled IHME, GBD 2019 (accessed 2022)
431,968 (348,434 - 534,361) 2018 Modelled IHME, GBD 2019 (accessed 2022)
432,584 (348,972 - 537,079) 2019 Modelled IHME, GBD 2019 (accessed 2020)
434,641 (351,031 - 539,362) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
29,100 (21,500 - 35,500) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
5.1 (4.09 - 6.39) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5.23 (4.71 - 5.76) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5.36 (4.83 - 5.91) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5.2 (4.69 - 5.74) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.98 (4.47 - 5.49) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.89 (4.39 - 5.41) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.87 (4.37 - 5.40) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.63 (4.15 - 5.15) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.15 (3.70 - 4.70) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.23 (3.78 - 4.74) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.43 (3.97 - 4.96) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.96 (3.52 - 4.49) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.94 (3.49 - 4.47) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.95 (3.51 - 4.48) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.04 (3.58 - 4.59) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.27 (3.77 - 4.87) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4.48 (3.96 - 5.12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
4.74 (4.17 - 5.43) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5.05 (4.42 - 5.77) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.24 (4.60 - 5.98) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.24 (4.61 - 5.99) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.32 (4.66 - 6.09) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.21 (4.57 - 5.97) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.25 (4.60 - 6) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.14 (4.51 - 5.88) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.98 (4.35 - 5.69) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5.1 (4.46 - 5.85) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5.08 (4.33 - 5.98) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5.1 (4.47 - 5.84) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5.1 (4.16 - 6.12) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5.1 (4.09 - 6.39) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,878 2016 Modelled WHO
1,960 (1,571 - 2,454) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,960 (1,571 - 2,454) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1,960 (1,599 - 2,355) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,957 (1,668 - 2,303) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,961 (1,721 - 2,247) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,961 (1,716 - 2,253) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,915 (1,675 - 2,191) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,979 (1,733 - 2,260) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2,018 (1,769 - 2,309) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,002 (1,754 - 2,293) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,012 (1,770 - 2,297) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,039 (1,787 - 2,335) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,005 (1,762 - 2,290) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,929 (1,691 - 2,206) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,812 (1,594 - 2,075) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,711 (1,514 - 1,955) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,630 (1,439 - 1,858) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,542 (1,366 - 1,752) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,511 (1,341 - 1,713) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,507 (1,337 - 1,710) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,517 (1,346 - 1,721) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,592 (1,417 - 1,803) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,621 (1,451 - 1,819) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,701 (1,525 - 1,906) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,777 (1,594 - 1,978) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,870 (1,677 - 2,075) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,878 (1,685 - 2,076) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,911 (1,716 - 2,106) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,993 (1,796 - 2,200) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,050 (1,848 - 2,261) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,995 (1,796 - 2,198) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
25 (22 - 28) 1990 Modelled IHME, GBD 2019 (accessed 2022)
24 (21 - 27) 1991 Modelled IHME, GBD 2019 (accessed 2022)
23 (20 - 25) 1992 Modelled IHME, GBD 2019 (accessed 2022)
22 (19 - 24) 1993 Modelled IHME, GBD 2019 (accessed 2022)
18 (16 - 20) 1995 Modelled IHME, GBD 2019 (accessed 2022)
20 (17 - 22) 1994 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 15) 1997 Modelled IHME, GBD 2019 (accessed 2022)
16 (14 - 18) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8 (7 - 9) 2012 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 10) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 10) 2014 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 10) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2016 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
26 (22 - 30) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
18 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2001
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.44 (%)
2019
(0.39 - 0.49(%))
IHME, GBD 2019 (accessed 2020)
HCV (RNA/cAg+)
1.19 (%)
2019
(0.96 - 1.47(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV (anti-HCV)
1.1 (%)
2016
(1 - 1.2(%))
ECDC

Hepatitis related deaths (national)

Modelled

HBV
1,755
2019
(1,380 - 2,203)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,960
2019
(1,571 - 2,454)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.01 (%)
2020, latest modelled
(0.01 - 0.02(%))
WHO

Prevalence PWID

HCV
57.90 (%)
2017, survey/surveillance
ECDC

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
79 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs